XWELL Inc (XWEL)
1.447
-0.04
(-2.91%)
USD |
NASDAQ |
Nov 21, 16:00
1.46
+0.01
(+0.93%)
Pre-Market: 20:00
XWELL Enterprise Value: 0.1013M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 0.1013M |
| November 20, 2024 | 0.3294M |
| November 19, 2024 | 0.4871M |
| November 18, 2024 | 0.6974M |
| November 15, 2024 | 1.196M |
| November 14, 2024 | 1.328M |
| November 13, 2024 | 1.44M |
| November 12, 2024 | 1.591M |
| November 11, 2024 | 1.149M |
| November 08, 2024 | 1.381M |
| November 07, 2024 | 1.276M |
| November 06, 2024 | 1.427M |
| November 05, 2024 | 1.696M |
| November 04, 2024 | 1.671M |
| November 01, 2024 | 1.547M |
| October 31, 2024 | 1.906M |
| October 30, 2024 | 2.116M |
| October 29, 2024 | 1.827M |
| October 28, 2024 | 2.011M |
| October 25, 2024 | 1.706M |
| October 24, 2024 | 1.801M |
| October 23, 2024 | 1.696M |
| October 22, 2024 | 2.064M |
| October 21, 2024 | 1.827M |
| October 18, 2024 | 2.064M |
| Date | Value |
|---|---|
| October 17, 2024 | 1.696M |
| October 16, 2024 | 2.228M |
| October 15, 2024 | 2.274M |
| October 14, 2024 | 1.959M |
| October 11, 2024 | 2.011M |
| October 10, 2024 | 1.915M |
| October 09, 2024 | 1.863M |
| October 08, 2024 | 1.223M |
| October 07, 2024 | 1.538M |
| October 04, 2024 | 1.591M |
| October 03, 2024 | 1.433M |
| October 02, 2024 | 1.775M |
| October 01, 2024 | 1.591M |
| September 30, 2024 | 1.591M |
| September 27, 2024 | -0.5448M |
| September 26, 2024 | -1.281M |
| September 25, 2024 | -1.281M |
| September 24, 2024 | -0.939M |
| September 23, 2024 | -0.755M |
| September 20, 2024 | -0.2294M |
| September 19, 2024 | 0.0071M |
| September 18, 2024 | -0.0717M |
| September 17, 2024 | 0.1385M |
| September 16, 2024 | -1.281M |
| September 13, 2024 | -1.491M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-15.11M
Minimum
Sep 28 2023
296.15M
Maximum
Jun 22 2020
35.29M
Average
16.01M
Median
Dec 27 2019
Enterprise Value Benchmarks
| Fonar Corp | 41.17M |
| ProPhase Labs Inc | 35.22M |
| Applied DNA Sciences Inc | -8.969M |
| Veracyte Inc | 2.744B |
| OncoCyte Corp | 41.59M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.75M |
| Revenue (Quarterly) | 8.422M |
| Total Expenses (Quarterly) | 13.04M |
| EPS Diluted (Quarterly) | -0.99 |
| Gross Profit Margin (Quarterly) | 24.38% |
| Profit Margin (Quarterly) | -56.40% |
| Earnings Yield | -224.7% |
| Normalized Earnings Yield | -208.49 |